JERUSALEM--(BUSINESS WIRE)--OurCrowd, the world’s leading equity crowdfunding platform has announced that Joel Maryles has joined as a Venture Partner to work with OurCrowd's portfolio companies on strategic issues including financings, partnerships, IPOs as well as M&A. He will carry the title of Chief Exit Officer (CXO).
In his three decade Wall Street career, Maryles was involved in $20B of transactions for Israeli tech companies including deals for leading companies, such as M-Systems, Teva, Galileo, Given Imaging, and Nice. Maryles founded Citigroup's Israel Investment Banking operations and managed it for over a decade, completing over sixty successful transactions, including IPOs, follow-on equity offerings, and merger and acquisitions.
Jon Medved, CEO of OurCrowd said, "With the addition of Joel Maryles we continue to build our team of extraordinary professionals with strong backgrounds. Joel will provide our portfolio of 60 startups with significant access to Wall Street and strategic finance expertise, and help them navigate the road to exit.”
Joel Maryles commented, "I have had the pleasure for thirty years to work with and invest in leading-edge technology and healthcare companies, both in Israel and the US. OurCrowd has built an impressive stable of companies with exciting technology and bright prospects. I look forward to working with these companies, drawing upon the knowledge and experience that I have gathered over my career on Wall Street, to help them grow and achieve their goals.”
Maryles currently serves as a board member of Radware (NASDAQ: RDWR), a provider of application delivery and network security products, and of EZchip (NASDAQ: EZCH), a fabless semiconductor company that provides Ethernet network processors for networking equipment.
Maryles holds a Bachelor of Science degree in Engineering from the University of Illinois and a Master of Business Administration from the University of Chicago.
OurCrowd is the world's largest equity crowdfunding platform for accredited investors to invest in Israeli and global companies. Managed by a team of well-known investment professionals and led by serial entrepreneur Jon Medved, OurCrowd vets and selects opportunities, invests its own capital and brings these startups to its accredited membership. OurCrowd investors must meet stringent accreditation criteria and invest a minimum of $10,000 per deal of their choice. OurCrowd provides post-investment support to its portfolio companies, assigning industry experts as mentors and taking board seats. OurCrowd has raised over $110M in equity crowdfunding for its 62 portfolio companies, which include leading companies, such as: Borro, BillGuard, Consumer Physics (SCiO), BioCatch, Abe’s Market, and ReWalk, OurCrowd’s first portfolio company to complete a successful IPO on the NASDAQ. Visit us online at: www.ourcrowd.com.
For Press Materials: http://blog.ourcrowd.com/index.php/press-release-joel-maryles/